skip to main content

PD Middle Molecule Limitation — ESENeph MCQ

Instant feedback + full explanation. One question, done properly.

HardPeritoneal DialysisPD Middle Molecule LimitationESENeph

Tolvaptan is started for rapidly progressive ADPKD. Which initial split dose and titration sequence matches Jinarc prescribing?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EUse 45+15 mg, 60+30 mg, then 90+30 mg at weekly intervals

Explanation lettering: C = shown as A · E = shown as B · D = shown as C · A = shown as D · B = shown as E

B is correct. Jinarc begins at 45 mg on waking and 15 mg eight hours later. If tolerated, it is titrated at intervals of at least one week to 60+30 mg and then the 90+30 mg target, maintaining the highest tolerable dose. The unequal split is designed for sustained V2-receptor blockade while limiting nocturnal aquaresis.

Reference: Jinarc 90 mg + 30 mg tablets SmPC: https://www.medicines.org.uk/emc/product/6854/smpc